NEW YORK — Kem-En-Tec Diagnostics, a world leader in developing environmentally safe, technologically advanced, and ready-to-use components for immunoassays, announced today that the company will be presenting at MEDICA 2013, in Düsseldorf, Germany November 20-23, 2013. Kem-En-Tec Diagnostics is also celebrating the company’s 25th Anniversary during its participation at the largest medical exhibition in the […]
Columbus, Nebraska – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Nebraska Public Power District (NPPD) announced today an agreement to purchase renewable energy credits from NextEra Energy Resources’ Steele Flats Wind Farm for the next 20 years. Energy from the recently completed 75-megawatt Steele Flats Wind Farm, located […]
MILFORD, Mass. — SeraCare Life Sciences, a manufacturer of life sciences tools, bulk plasma, and quality controls for diagnostic companies and clinical laboratories, announced availability of IVD labeled ACCURUN® controls for Women’s Health. These Human Papilloma Virus (HPV) and Chlamydia trachomatis/Neisseria gonorrhea (Ct/Ng) offerings are cellular-based independent controls used by clinical laboratories to challenge their […]
SEATTLE — NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the availability of the nCounter® Dx Analysis System for high-complexity, CLIA-certified laboratories. The nCounter Dx Analysis System is the only platform 510(k) cleared by the U.S. Food and Drug Administration to run the […]
Pediatric hospitals to share data and genomic testing infrastructure for the benefit of patients Cambridge, Nov 12— Cincinnati Children’s Medical Center has partnered with Claritas Genomics, a company formed by Boston Children’s Hospital and Life Technologies Corporation (NASDAQ: LIFE), to provide genomics-based diagnostics for pediatric patients. Cincinnati Children’s will work with Claritas and Boston Children’s […]
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the availability of the CE-marked BD MAX MRSA XTassay in Europe for use on the BD MAX™ System. The assay uses eXTended detection technology to accurately identify a broad range of methicillin-resistant Staphylococcus aureus […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Francis deSouza to the role of President. Mr. deSouza will report to Chief Executive Officer Jay Flatley and will lead Illumina’s business units and the core functions responsible for envisioning, developing and producing the company’s products. He will also become part of Illumina’s executive […]
WASHINGTON –– Speaking at the U.S. News & World Report Hospital of Tomorrow forum Tuesday, Northrop Grumman Corporation’s (NYSE:NOC) Amy Caro, vice president of health IT programs, said advances in genomics and more widespread use of molecular data will enhance healthcare and improve health outcomes but ensuring the security of personal data is key to […]
TUCSON, Ariz. — Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Mark C. Miller has been appointed to its Board of Directors. Mr. Miller currently serves as Executive Chairman and director of Stericycle (NASDAQ: […]
SAN DIEGO – TriLink BioTechnologies, Inc. (TriLink) announced that it has signed a new licensing agreement with Biofortuna Ltd. (Biofortuna) for use of its CleanAmp™ dNTPs in Biofortuna’s freeze-drying (lyophilized) contract development and production service. In 2010 Biofortuna licensed TriLink’s CleanAmp™ dNTPs for use in their unique molecular diagnostic kits, SSPGo™, which are now distributed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
